Government bureaucrats are operating behind closed doors to set medicine prices without disclosing for months how they arrived at the price or how much patient and provider input was used,” said Alex Schriver, senior vice president of the Pharmaceutical Research and Manufacturers of America.
Joe Biden to make initial offers in Medicare drug-price negotiation
→
"We’ve long supported changes that would lower costs for patients at the pharmacy, including a cap on out-of-pocket costs for Medicare Part D beneficiaries," said Alex Schriver, the senior vice president of public affairs at PhRMA. "However, we won’t support a government price-setting scheme that allows a single agency to dictate the price of medicines and what future treatments and cures are worth developing."
Joe Biden says all 10 selected drugmakers will participate in Medicare price negotiations
→
